Hetero launches generic Covid-19 drug 'Favivir' at Rs 59 per tablet

It improves treatment accessibility to a significant amount of Covid-19 patient population, which have mild to moderate symptoms,Hetero said

Drug firm Hetero on Wednesday said it has launched genericoral antiviral drug Favipiravir used forthe treatment of patients with mild to moderate Covid-19,in India under the brand name 'Favivir' at Rs 59 per tablet.

The company has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI), Hetero said in a statement.

Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of Covid-19, it added.

Themedication has demonstrated positive clinical